Thursday, September 5, 2013

Mallinckrodt's extended-release pain drug meets main goal of study

(Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions.

No comments:

Post a Comment

Subscribe Now: Feed Icon